

Fundamental dimension Equity attribute | CZBCPeer $16.000.00% Cap $89.99MP/E 43.3x QuantScore39/100 | CBKMPeer $31.900.00% Cap $100.7MP/E 8.7x QuantScore52/100 | CIWVLeader $56.86▲+0.73% Cap $96.80MP/E 7.7x QuantScore67/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
91/100 |
45/100 |
73/100 |
Valuation Multiples, PEG & DCF upside | 12/100 | 71/100 | 100/100 |
Health Piotroski, Altman Z, leverage & liquidity | 25/100 | 30/100 | 27/100 |
Growth Revenue / earnings growth & margins | 25/100 | 63/100 | 71/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 43.3x | 8.7x | 7.7x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | 43.4x | 9.7x | 5.9x |
Price / Sales | 2.6x | 1.5x | 1.9x |
Price / Free Cash Flow | — | 163.2x | — |
PEG ratio | -2.21 | 0.32 | 0.25 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | 5 / 9 | 4 / 9 |
Altman Z-Score | 0.23 (Distress) | 0.38 (Distress) | -0.85 (Distress) |
Total debt / equity | 0.26 | 0.04 | 0.00 |
Quick ratio | 0.8x | — | — |
Interest coverage | 0.5x | 0.7x | 1.3x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -13.8% | +15.1% | +6.4% |
Net income growth YoY | -26.2% | +28.8% | +35.0% |
Gross margin (TTM) | 85.0% | 68.3% | 71.1% |
Operating margin (FY) | 8.0% | 20.1% | 29.4% |
FCF margin (FY) | 22.1% | 14.2% | 28.2% |
5. Trailing price performancePrice change over period |
1M return | +0.4% | -2.4% | +11.5% |
3M return | +3.2% | +6.4% | +16.1% |
6M return | +18.1% | +20.6% | +13.7% |
Year to date | +57.6% | +22.2% | +73.6% |
1Y return | +64.1% | +36.4% | +69.0% |
3Y return | +33.3% | +111.3% | +170.8% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $9.88 -38.3% premium | $32.65 +2.4% upside | $101.60 +78.7% upside |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |